Is MGRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.

MGRX (Mangoceuticals, Inc. Common Stock) Stock Analysis - Financials

Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of September 22, 2026, MGRX trades at $0.44 with a market cap of $10.27M and a P/E ratio of -0.43. MGRX moved -8.15% today. Year to date, MGRX is -39.12%; over the trailing twelve months it is -79.98%. Its 52-week range spans $0.16 to $6.15. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are MGRX's key financials?

MGRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MGRX recently traded at $0.44. Market cap is $10.27M. P/E ratio is -0.43. Revenue is $315.23K.

MGRX Key Metrics

Key financial metrics for MGRX
Metric	Value
Price	$0.44
Market Cap	$10.27M
P/E Ratio	-0.43
EPS	$-1.02
Dividend Yield	0.00%
52-Week High	$6.15
52-Week Low	$0.16
Volume	439.95K
Avg Volume	0
Revenue (TTM)	$315.23K
Net Income	$-15.10M
Gross Margin	54.43%

MGRX Analyst Consensus

MGRX analyst coverage data. Average price target: $0.00.

Common questions about MGRX

What are MGRX's key financials?: MGRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MGRX recently traded at $0.44. Market cap is $10.27M. P/E ratio is -0.43. Revenue is $315.23K.
Is MGRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.